NCT03162458 - Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections | Biotech Hunter

Enrollment

142

Participants

Timeline

Start Date

January 22, 2015

Primary Completion Date

April 29, 2015

Study Completion Date

April 29, 2015

Conditions

Acute Upper Respiratory Infections

Interventions

DRUG

Anaferon for children (liquid dosage form)

10 drops per dose. Day 1: 10 drops every 30 minutes for the first 2 hours, followed by three more doses regularly spaced during the rest of the day. Day 2 to 5: 10 drops three times daily.

DRUG

Placebo (liquid dosage form)

10 drops per dose. Day 1: 10 drops every 30 minutes for the first 2 hours, followed by three more doses regularly spaced during the rest of the day. Day 2 to 5: 10 drops three times daily.

Trial Locations (7)

129515

"LLC Center for Vaccine Prevention DIAVAKS", Moscow

150000

"Federal State Budgetary Educational Institutionof Higher Education Yaroslavl State Medical University of the Ministry of Healthcare of the Russian Federation", Yaroslavl

192212

"St. Petersburg State Budgetary Health Care Institution Сity Polyclinic №44", Saint Petersburg

193312

"St. Petersburg State Health Care Institution Children's City Polyclinic No. 45 Nevsky District", Saint Petersburg

194356

Alliance Biomedical-Russian Group LLC, Saint Petersburg

196650

"St. Petersburg State Budgetary Healthcare Institution Children's City Hospital No. 22", Saint Petersburg

614066

"Municipal Health Care Institution City Child Health Clinical Polyclinic №5", Perm